GlassScriptPhysician profile
Marc I Storch
NPI 1376659466
$11,291.45
in general payments reported to CMS, 2019-2025
21 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,673 · 2020: $893 · 2021: $1,536 · 2022: $1,745 · 2023: $1,772 · 2024: $2,185 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,048 · Education: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,048.30 |
| Education | $394.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,597.02 | 2019-2025 | Tremfya, Simponi Aria |
| Amgen INC. | $3,192.72 | 2019-2025 | Enbrel, Evenity, Prolia |
| Pfizer INC. | $1,570.06 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $600.72 | 2019-2025 | |
| Ucb, INC. | $525.75 | 2020-2024 | Cimzia |
| Glaxosmithkline, LLC. | $389.36 | 2019-2025 | Benlysta |
| Genentech USA, INC. | $315.50 | 2019-2021 | |
| Lilly USA, LLC | $231.99 | 2019-2021 | |
| Genzyme Corporation | $178.54 | 2019-2024 | |
| Janssen Scientific Affairs, LLC | $142.07 | 2025 | Tremfya |
| Celgene Corporation | $136.30 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $77.56 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $74.99 | 2019 | |
| Abbvie INC. | $63.47 | 2019-2025 | |
| Radius Health, INC. | $51.73 | 2019-2024 | Tymlos |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $39.95 | 2019 | |
| Aurinia Pharma U.S., INC. | $35.15 | 2021 | |
| Sandoz INC. | $21.99 | 2024 | Hyrimoz |
| Alexion Pharmaceuticals, INC. | $16.72 | 2024 | Strensiq |
| Organon LLC | $15.46 | 2023 | Hadlima |
| Horizon Therapeutics Plc | $14.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Storch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.